The results of combined surgical treatment of thromboangiitis obliterans and critical lower limb ischemia using prolonged epidural analgesia and autohemotherapy with ozone-Reference-Cited by-同舟云学术

The results of combined surgical treatment of thromboangiitis obliterans and critical lower limb ischemia using prolonged epidural analgesia and autohemotherapy with ozone

Published:2016 Issue:9 Volume: Page:45
ISSN:0023-1207
Container-title:Khirurgiya. Zhurnal im. N.I. Pirogova
language:en
Short-container-title:Khir. Z. im. N.I. Pirogova

Author:

Abyshov N. S.,Abdullayev A. G.,Zakirdzhaev E. D.,Guliyev R. A.,Akhmedov M. B.,Tagizade G. T.,Zeynalova G. M.,Mamedova L. D.

Publisher

Media Sphere Publishing Group

Subject

General Medicine

Reference33 articles.

1. Gavrilenko A.B., Skrylev S. I. Khirurgicheskoe lechenie bol'nykh s kriticheskoi ishemiei nizhnikh konechnostei pri porazheniyakh arterii bedrenno-podkolenno-bertsovogo segmenta. Khirurgiya 2004;8: 36-42.

2. Dibirov M. D., Dibirov A. A., Gadzhimuradov R. U. i dr. Distal'nye rekonstruktsii pri kriticheskoi ishemii nizhnikh konechnostei u bol'nykh starshikh vozrastnykh grupp. Khirurgiya. 2009;1: 49-52.

3. Sukovatykh B.S., Knyazev V.V. Prognozirovanie razvitiya kriticheskoi ishemii u bol'nykh khronicheskimi obliteriruyushchimi zabolevaniyami arterii nizhnikh konechnostei. Khirurgiya 2008; 3:25-29.

4. Olin J.W., Shih A. Thromboangiitis obliterans (Buerger's disease). Curr. Opin. Rheumatol., 2006, Vol. 18, N 1, p. 18-24.

5. Shionoya S. Buerger's disease: diagnosis and management. Cardiovasc.Surg., 1993, Vol. l, N 3, p. 207-214.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the role of adjunctive ozone therapy in subperiosteal dental implantology: A case study and comprehensive literature review;Medical Reports;2024-06

2. The role of ozone treatment as integrative medicine. An evidence and gap map;Frontiers in Public Health;2023-01-16

3. Effect of revascularization on IL-6 and TNF-α in patients with thromboangiitis obliterans;Experimental and Therapeutic Medicine;2018-02-20